• Treffer 1 von 2
Zurück zur Trefferliste

Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro

  • Gout is the most common arthritic disease in human but was long neglected and therapeutic options are not satisfying. However, with the recent approval of the urate transporter inhibitor lesinurad, gout treatment has experienced a major innovation. Here we show that lesinurad possesses considerable modulatory potency on peroxisome proliferator-activated receptor γ (PPARγ). Since gout has a strong association with metabolic diseases such as type 2 diabetes, this side-activity appears as very valuable contributing factor to the clinical efficacy profile of lesinurad. Importantly, despite robustly activating PPARγ in vitro, lesinurad lacked adipogenic activity, which seems due to differential coactivator recruitment and is characterized as selective PPARγ modulator (sPPARγM).

Volltext Dateien herunterladen

Metadaten exportieren

Metadaten
Verfasserangaben:Pascal HeitelORCiDGND, Leonie Gellrich, Jan Peter HeeringORCiDGND, Tamara GöbelORCiD, Astrid Stefanie KahntORCiDGND, Ewgenij ProschakORCiDGND, Manfred Schubert-ZsilaveczGND, Daniel MerkORCiDGND
URN:urn:nbn:de:hebis:30:3-471146
DOI:https://doi.org/10.1038/s41598-018-31833-4
ISSN:2045-2322
Pubmed-Id:https://pubmed.ncbi.nlm.nih.gov/30202096
Titel des übergeordneten Werkes (Englisch):Scientific reports
Verlag:Macmillan Publishers Limited, part of Springer Nature
Verlagsort:[London]
Dokumentart:Wissenschaftlicher Artikel
Sprache:Englisch
Jahr der Fertigstellung:2018
Datum der Erstveröffentlichung:10.09.2018
Veröffentlichende Institution:Universitätsbibliothek Johann Christian Senckenberg
Datum der Freischaltung:25.09.2018
Freies Schlagwort / Tag:Drug safety; Metabolic syndrome; Target identification
Jahrgang:8
Ausgabe / Heft:1, Art. 13554
Seitenzahl:11
Erste Seite:1
Letzte Seite:11
Bemerkung:
Rights and permissions: Open Access: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
HeBIS-PPN:438464206
Institute:Biochemie, Chemie und Pharmazie / Pharmazie
DDC-Klassifikation:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Open-Access-Publikationsfonds:Biochemie, Chemie und Pharmazie
Lizenz (Deutsch):License LogoCreative Commons - Namensnennung 4.0

OPUS4 Logo